Ani Pharmaceuticals (ANIP) Revenue Growth (5y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.19% |
| Dec 31, 2025 | 33.97% |
| Sep 30, 2025 | 33.87% |
| Jun 30, 2025 | 34.25% |
| Mar 31, 2025 | 31.69% |
| Dec 31, 2024 | 31.77% |
| Sep 30, 2024 | 23.64% |
| Jun 30, 2024 | 20.49% |
| Mar 31, 2024 | 21.04% |
| Dec 31, 2023 | 18.18% |
| Sep 30, 2023 | 21.06% |
| Jun 30, 2023 | 19.78% |
| Mar 31, 2023 | 18.10% |
| Dec 31, 2022 | 14.79% |
| Sep 30, 2022 | 11.72% |
| Jun 30, 2022 | 10.53% |
| Mar 31, 2022 | 11.97% |
| Dec 31, 2021 | 9.78% |
| Sep 30, 2021 | 6.21% |
| Jun 30, 2021 | 9.18% |